What Researchers Did
Researchers retrospectively compared the efficacy of 2.0 atmospheres absolute (ATA) versus 2.2 ATA hyperbaric oxygen (HBO2) therapy for sudden sensorineural hearing loss (SSNHL) in 160 patients.
What They Found
Both the 2.0 ATA and 2.2 ATA HBO2 groups achieved higher hearing gain (20.92 dB and 20.47 dB, respectively) compared to the control group (11.94 dB) at 250-500 Hz. At 1,000-2,000 Hz, only the 2.2 ATA group showed significant improvement (19.70 dB vs. 10.56 dB control), while neither HBO2 group demonstrated desired effects at 4,000-8,000 Hz.
What This Means for Canadian Patients
Canadian patients experiencing sudden sensorineural hearing loss might benefit from hyperbaric oxygen therapy, with higher therapeutic pressures potentially offering better outcomes for certain frequency ranges. This suggests that optimizing HBO2 pressure could enhance treatment efficacy for this condition.
Canadian Relevance
This study was conducted in China and has no direct Canadian connection. Therefore, its direct relevance to the Canadian healthcare system is limited.
Study Limitations
As a retrospective study, it is subject to inherent biases and limitations in controlling for all confounding factors.